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Abstract  Objective: To investigate the effect of combination epidural bupivacaine and 
intravenous parecoxib analgesia on  immune response in patients who underwent 
open reduction and internal fixation of the lower limb under epidural anesthesia.  
 Methods: This research was conducted using the randomized, placebo-controlled 
double blind trial method on 52 patients who were randomly divided into 2 
groups: the Parecoxib group which received 40 mg intravenous parecoxib for 30 
minutes before incision and the control group which received an equal volume of 
0.9% normal saline. Both groups received epidural anesthesia and postoperative 
epidural 0.125% bupivacaine analgesia continously. Venous blood samples were 
obtained before parecoxib administration, 2 and 24 hours after the surgery. The 
data were analyzed using Mann Whitney U and independent t tests (p<0.05). 
 
 Results: There was a significant difference between the two groups (p<0.05) in 
IL-1β, IL-6, IL-10 levels and proinflammatory to anti-inflammatory ratio, 2 hours 
after surgery.
 
 Conclusions: Multimodal analgesic combination of 40 mg IV parecoxib and 
0.125% bupivacaine epidural analgesia have the effect to alter and stabilize the  
systemic immune response.
 
 Keywords: Cytokines, epidural analgesia, interleukins, immune response, 
                      parecoxib, tissue damage 
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Introduction
Postoperative pain brings a significant impact 
on patients. However, the management of the 
postoperative pain is still occasionally overlooked 
even though there are recent developments and 
extensive understandings on postoperative pain 
mechanism. Almost half of all postoperative 
patients had not received proper postoperative 
pain management and about 80% of them were 
still in acute pain postoperatively.1 Research 
conducted in Maastricht University Hospital, the 
Netherlands, showed that about 41% of 1,490 
postoperative patients were still in moderate 
to severe pain on the 1st to 4th day post-surgery 
in spite of the standard pain management 
protocol. About 30–55% of post abdominal 
surgery patients were still in moderate to severe 
pain on the 1st day, about 20–71% of post lower 
extremity surgery and 30–64% of post spinal 
surgery were still in moderate to severe pain on 
the 1st to 4th day.2
The inflammation responses to postoperative 
trauma may induce the neuroendocrine stress 
responses. The inflamed peripheral tissue 
produces cytokines, i.e. Interleukin-1β (IL-β), 
IL-2, IL-6 and tumor necrosis factors (TNF). The 
humoral signal induces the cyclooxygenase 2 
(COX-2) activity and, therefore, prostaglandin 
synthesis in central nervous system (CNS) which 
leads to sensitization. This cannot be inhibited 
effectively by regional anesthesia. However, the 
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centrally-acting COX-2 inhibitor administration 
will reduce this activity.3 The circulation of the 
T-helper cell (Th) is associated with cytokine 
expression. Th1 cell is associated with immune 
cells, e.g. interferon γ (INF-γ), IL-2 while Th2 
produces IL-4, IL-5 and IL-10, which are associated 
with the immunosupression response. The 
balance of IL-6 and IL-10 is an important factor 
in the series of immune responses.4  The COX-
2  expression is stimulated by proinflammatory 
cytokine and inhibited by anti-inflammatory 
mediators, such as IL-10 and IL-4, through 
transformation growth factor-beta (TGF-beta).5
A study on preemptive analgesia by using 
epidural technique associated with pain score 
and the cytokine production proved that the 
use of epidural preemptive could reduce the 
pain score and production of IL-1β, IL-6, IL-1ra.6 
On the other hand, another research showed 
that epidural technique could only inhibit the 
neural line and could not inhibit the humoral 
line.7 The use of rofecoxib combination and 
spinal anesthesia on pelvic surgical operation 
showed reduction in IL-6 and prostaglandin 
E2 (PGE2) levels in cerebrospinal fluid (CSS), 
plasma, and wound side while TNFα dan IL-
1β could not be detected both in plasma and 
CSS.8 A study on the effect of a single parecoxib 
administration on cytokine response, and 
stress response as well as the administration 
of ophthalmological postoperative analgesia 
showed significant decreases in IL-6, IL-8, 
cortisol adrenocorticotropic, and VAS (p<0.001) 
compared to the control groups. There were no 
decreases in epinephrine and norepinephrine 
levels in both group.9
Another study suggested that the use of 
multimodal analgesia with IV tramadol and 
IV flurbuprofen combination in thoracotomy 
postoperative pain management were able to 
reduce the pain score, IL-6, and postoperative 
C-reactive protein (CRP) compared to the pain 
score in the control groups. The TNF-α level was 
similar for both groups.10 Epidural preemptive 
analgesia showed lower pro-inflammation/anti-
inflammatory cytokine ratio than the control 
groups, but the difference was not significant. 
This proved that epidural preemptive could 
not reduce central sensitization through the 
hormonal line.11
The effect of centrally-acting multimodal 
analgesia COX-2 inhibitor combined with 
epidural analgesia on immune response and 
pain intensity has not been studied extensively. 
Hence, in order to improve our understanding, 
holistic studies are needed to examine the 
inflammation and anti-inflammatory cytokine 
level as well as the IL-6/IL-10 ratio in patients 
receiving  40 mg IV parecoxib and with 0.125% 
epidural bupivakain analgesic combination. 
Methods
This study was conducted in Dr. Wahidin 
Sudirohusodo General Hospital, Makassar from 
April to July 2012 and was approved by the 
Ethics Committee of Hasanuddin University 
Makassar. All patients who met the inclusion 
criteria were consecutively enrolled. This study 
was performed using the clinical double-blind 
randomized case-control study design.
Male patients who underwent open reduction 
internal fixation elective surgical operation of 
lower hip fracture with epidural anesthesia and 
who met the following inclusion criteria, i.e. PS 
ASA 1–2, 18–50 years of age, height more than 
155 cm and normal BMI, were included in this 
Table 1 Demographic Characteristics of Patients
Variable
Group
p value*) Parecoxib (n=26)  Control (n=26)
Range Mean±SD Range Mean±SD
Age 23–50 35.96±10.25 18–48 29.15±9.43  0.61
Height 157–174 16.8 ±4.43 154–173 165.15± 5.51 0.53
BMI 20.20–24.38   21.93±1.38 20,01–24,80 21.18±1.36 0.36
Duration of operation 100–175 141.73±20.73 100–175 139.61±25.33 0.57
Consumption of local anesthesia 90–135 110.76±22.87 90–135 110.76±22.87 0.57
PS ASA 1–2 1.00 1–2 1.00 0.81
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study. Patients who had contraindications for 
epidural catheter placement, history of allergy 
to study medicines, cardiovascular disease, renal 
failure, liver damage, signs of SIRS, under NSAID 
less than 5 days before the procedure, and 
under corticosteroid were excluded. Patients 
who experienced intraoperative complications, 
needed resurgery during observation period, 
needed blood transfusion, had non-optimal 
epidural anesthesia, and underwent more than 
3-hour operative procedure were also excluded. 
Samples were obtained using consecutive 
random method. Fifty two patients were 
enrolled and divided into 2 groups, which was 
parecoxib group and  control group.
Patients were given 5 mg alprazolam prior 
to the operation as the inclusion criteria met. 
Epidural catheter  insertion at the level of of  L2–3 
or L3–4 was done at the operation room. Fourty 
milligrams intavenous Parecoxib was given to 
the parecoxib group about 30 minutes prior to 
incision, while the control group were given 2 
cc 0.9% NaCL. Bupivakain epidural anesthesia, 
0.5% 1–2 mL/dermatome, was administered 
30 minutes prior to the incision until the block 
reached T12-S2. During the procedure, patients 
were sedated with 25–100 µg/kg/minute IV 
propofol. After the procedure, both groups were 
given continuous 0.125% bupivacaine, 5 cc/hour, 
as the post-operative analgesia. Blood samples 
was taken 2 and 24 hours after the procedure 
and the IL-1β and IL-6 serum levels were 
measured. The pain intensity was assessed using 
Numeric Rating Score (NRS) and 3 mL of 0.125% 
bupivacaine was given when the NRS was more 
than 4/10. The Human Interleukin Immunoassay 
Quantikine HS serum (R & D System) was used 
to measure the cytokine level using the Enzyme 
Linked Immunosorbent Assay with ELISA Reader 
Organon 680 (Biorad) equipment.
The collected data were then processed 
with SPSS 15.0 software for Windows. Data 
were examined using t test for characteristics of 
samples. The differences of variables between 
both groups were examined using Mann-
Whitney U-test. The number of samples needed 
in each group were 26 (α=0.05 and power=0.8). 
Differential test between variables in both 
groups was considered significant if p<0.05. 
Data are presented in mean ±SD and minimum-
maximum/median.
Results
Demographic characteristics of both groups 
in age,height, body mass index, duration of 
operation, consumption of local anesthesia and 
ASA between the two group, therefore the two 
group were considered homogenous (Table 1). 
The difference of IL-1β level between the 
parecoxib group and the control group was not 
statistically significant (p>0.05), both in pre-
operation and 24 hours post-operation levels. 
At two hours after the surgery, the IL-1β level 
in parecoxib group was significantly different 
(p<0.05) from the control group (Fig. 1).
The IL-6 average value in parecoxib group 
and control group was not significantly different 
in pre-operation (p>0.05) and 24 hours post-
operation (p>0.05). However, based on the ob at 
2 hours of post-operation, the parecoxib group 
showed a significantly lower level (p<0.05) than 
the control group (Fig. 2).
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Interleukin 10 level in both groups increased 
at two hours post-operation and no significant 
difference was found between the level in the 
parecoxib group (4.46±3.51) and the control 
group (2.44 ±1.18) (p=0.028) (Fig. 3).
Discussion
Interleukin -1β level
Interleukin-1β, which is a protein precursor, is 
produced by the macrophages and monocytes, 
known as non-immune cells, that is activated 
by fibroblast and endothelial cell during the 
occurence of tissue damage, infection, invasion 
and inflammation. It is now found that IL-1β also 
appears on nociceptive neurons in the dorsal 
root ganglion. Interleukin-1β contributes to the 
systemic inflammation through COX-2 activation 
to form PGE2. The result of this study shows that 
the IL-1β level in the parecoxib group decreased 
at 2 hours post-operation (p<0.05), which is 
significantly different from the control group. 
However, 24 hours after operation, the IL-1β 
level in both groups decreased.
Another study combining spinal anesthesia 
and rofecoxib shows that the IL-1β level was 
undetected in plasma and LCS at 1, 3, 9, and 24 
hours after surgery, and was only found in fluid 
from the drain of the surgery side.8
A study on ophthalmological surgery shows 
that there was no significant difference (p>0.05) 
in IL-1β level between groups with parecoxib and 
without parecoxib.9 In that particular study, the 
IL-1β level showed a tendency to incline in both 
groups, with the parecoxib group showing less 
increase.
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Interleukin-6 Level
Surgical procedures are associated with tissue 
damages that activate both local and systemic 
nociceptive and inflammatory responses. This 
is then followed by proinflammatory cytokine 
increases, including the IL-6.8 The Interleukin-6 
as the proinflammatory cytokine plays major 
roles in the acute protein phase of the tissue 
damages resulting from surgical trauma. From 
all body responses to surgical trauma, the IL-6 
level is reported to be the sensitive indicator of 
surgical stress. The Interleukin-6 concentration 
in a normal condition is usually low and may not 
be detected.10 After a trauma, the plasma IL-6 
concentration can be detected in 60 minutes and 
will reach its peak after  4–6 hours. It starts to 
decrease between 24–48 hours after the trauma; 
however, it can persist until 10 days. Interleukin-6 
is the most sensitive marker of tissue damages. 
The longer the IL-6 persists in the plasma, the 
higher the  post-operative morbidity will be.13
The results of control group in this study are 
in agreement with the theories about IL-6. It is 
found that the IL-6 level increased at the 2nd and 
24th hour after surgery (p<0.05).
This finding is in line with the findings in a 
study performed on patients who underwent a 
transabdominal hysterectomy procedure using 
epidural analgesia preemptive technique, which 
was followed by Patient Controlled Epidural 
Analgesia (PCEA), where the IL-6 level increased 
in the first 24 hours post-operation (p<0.03) but 
it was lower than PCEA group (p<0.04).6
The IL-6 dynamic in the control group is in line 
with the IL-6 serum level dynamic in a study on 
patients who underwent lower extremity surgical 
operation with epidural preemptive technique.11 
Interleukin-6 will directly and indirectly affect the 
production of COX-2 and prostaglandin through 
IL-1. It is presumed that IL-6 can also activate the 
glia cell.13
It is stated that two pathways may be 
induced by peripheral inflammation. First, it 
induces the production and spread of COX-
2 and Prostaglandin E synthase (PGES) at the 
inflammation site, leading to the sensitization of 
nerves innervating the injured tissue by reducing 
their threshold and increasing their excitability. 
Second, the humoral pathway will be induced 
by the peripheral inflammation and this will 
increase the production and spread of COX-2 in 
CNS through NF-kβ by IL-1β, TNF-α, and IL-6.7
The results of this study show that the IL-6 
level in the parecoxib group decreased 2 hours 
after the surgery when it is compared  to the pre-
surgical value (p<0.05) and it increased again at 
24 hours after surgery (p<0.05). In the control 
group, the IL-6 level keeps increasing during 24 
hours after the surgery. There is a statistically 
significant difference of IL-6 level in both groups, 
particularly at two hours after the surgery 
(p<0.05). No significant difference in IL-6 level 
between both groups before the surgery and 
24 hours after surgery (p>0.05). These findings 
are presumably resulted from the inhibition of 
prostaglandin synthesis by parecoxib, which in 
turn affects the IL-6 production.
The Interleukin-6 production is initiated by the 
PGE2 receptor agonists. E-series prostaglandin 
receptors (EP) are the stimulated EP1 which 
enhances mobilization of calcium (Ca) from 
extracellular to intracellular compartment, while 
EP2 and EP4 receptors as G-protein-coupled 
receptors activate the cAMP and NF-kβ level.14
Recently, it is discovered that inflammation 
responses caused by surgical trauma cannot be 
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effectively inhibited merely by peripheral nerve 
inhibition or single neuraxial block. Peripheral 
inflammation induces COX-2 spread and  PGES 
expression in CNS. Studies on animal subjects 
found that the proinflammatory cytokine, IL-6, 
induces COX-2, both in the inflamed peripheral 
tissue and CNS. In postoperative pain, IL-6 is 
known as a major mediator that increases the 
COX-2 in the CNS. New evidence has shown 
that parecoxib administration works centrally 
by inhibiting the COX-2; therefore, decreasing 
the expression of PGE2. This is different from 
ketorolac since this agent inhibits the COX-2 
peripherally.15 
The results of this study support the findings in 
a study on preemptive analgesia that used 40 mg 
parecoxib adminitered intramuscularly before an 
ophthalmological surgery was performed under 
general anesthesia.9 It has been proven that the 
IL-6 plasma level in early post-operation until 6 
hours post-surgery decreases (p<0.05) compared 
to the control group but the difference of IL-6 
level at 24 hours after surgery is not significant 
compared to the control group.9
Based on a previous study that used oral 
preemptive COX-2 inhibitor combined with spinal 
anesthesia in arthroplasty, it is found that the 
IL-6 plasma experienced dynamic increases at 
the first 1, 3, 9, and 24 hours, and then decreases 
at 30 hours post-operation (p<0.05). Overall, the 
IL-6 level is lower than in the control group. This 
study is also supported with the measurement of 
PGE2 plasma level, which decreases at all times 
of the postoperative assessment (p<0.05).8
The results of this study contradicts findings 
from a previous study that involved the use of 
IV COX-2 inhibitor in thoracotomy patients.  In 
that study, the IL-6 level in both  study groups 
increased until 24 hours after the surgery and 
decreased after that point. However, the IL-6 
level in the treatment group was lower than in 
the control group (p<0.05).10
Differences of IL-6 dynamic in those studies 
may be caused by the use of different types of 
COX-2 inhibitors. The similarity found among 
these studies is that in the group receiving COX-2 
inhibitor, the IL-6 level is found to be lower than 
in the control group, although the IL-6 increases 
at the first 24 hours  after surgery. These findings 
show that the administration of COX-2 inhibitor 
has an effect on the IL-6 dynamic and level.
Therefore, a suggestion is proposed that the 
administration of 40 mg IV parecoxib 30 minutes 
before a surgical incision can reduce and stabilize 
the IL-6 level. From this, we can conclude that 
parecoxib affects the dynamic of IL-6.
Interleukin-10 Level
The involvement of IL-10 in pain is thought to 
be through the effect on PGE2. The Interleukin 
10 can inhibit the production of prostaglandin 
(PG) from peripheral blood mononuclear cells 
which is stimulated by the proinflammation 
cytokine. Anti-inflammatory cytokine increases 
after a trauma to maintain the balance 
between the anti-inflammation cytokine and 
the proinflammatory cytokines. The Interleukin 
10 also inhibits the production of PG through 
a feedback mechanism.17 Results of this study 
show that the level of IL-10 increases in both 
groups and the difference is not significant. This 
shows that epidural analgesia, with or without 
parecoxib, causes an anti-inflammatory action 
through IL-10 response. This study is in line with 
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another study that found IL-10 level increase 
after parecoxib administration.17
Proinflammatory to anti-inflammatory cytokines 
ratio
The balance between proinflammatory and 
anti-inflammatory cytokines are very important 
to maintain the homeostasis. In this study, the 
parecoxib group has lower IL-6/IL-10 and the IL-
1β/IL-10 ratios at the 2nd hour post-operation 
compared to control group. This shows that the 
administration of parecoxib has an effect on the 
systemic immune response.  Peak levels of anti-
inflammatory cytokine IL-10 occurs two hours 
after the surgery and is higher in the parecoxib 
group. An increase in the ratio of IL-6 to IL-10 
indicates a correlation with a poor outcome. 
This study has in line with the previous study.18 
A different result is shown in an animal study in 
which the IL-6 and IL-10 levels decreases after 
parecoxib administration with poor outcome.
Multimodal Analgesia
The multimodal analgesia concept has been 
introduced more than a decade ago as a 
technique to increase the effect of analgesia 
and decrease unexpected incidences related to 
the use of opioid. The rationale for this strategy 
is the achievement of sufficient analgesia due 
to the additive or synergistic effects between 
different classes of analgesics.3 This method can 
decrease the dosage of each individual drug, 
thus decreasing the adverse effects from each 
drug used in surgical procedure. Nowadays, the 
American Society of Anesthesiologist Task Force 
on Acute Pain Management suggested the use of 
this multimodal analgesia.3,18,19 
The use of multimodal analgesia technique 
aims to decrease the stress response caused 
by surgical operations, reduce the mobility 
pain, ease the body recovery after surgery and 
increase the clinical improvement as well as 
decreasing the side effects of medications.20
      In conclusion, the combination of 40 mg of 
IV parecoxib and 0.125% bupivacaine epidural 
analgesia can change and stabilize the systemic 
immune response. This combination technique 
can also be used as a preventive multimodal 
analgesia to prevent chronic pains. Further 
studies are needed to measure the change in 
prostaglandin level as a direct effect from COX-
2 inhibitor and also to observe patients’ clinical 
outcome.
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